GSK renews malaria efforts. GlaxoSmithKline Biologicals.
Kenyon
G
G
D000284:Administration, Oral; D017954:Africa South of the Sahara; D000962:Antimalarials / Q000008:administration & dosage; D002648:Child; D004345:Drug Industry; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000302:isolation & purification; D014944:World Health Organization
D000962:Antimalarials; D017780:Malaria Vaccines